» Articles » PMID: 1796039

Percutaneous Penetration Kinetics of Nitroglycerin and Its Dinitrate Metabolites Across Hairless Mouse Skin in Vitro

Overview
Journal Pharm Res
Specialties Pharmacology
Pharmacy
Date 1991 Oct 1
PMID 1796039
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The percutaneous penetration kinetics of the antianginal, nitroglycerin (GTN), and its primary metabolites, 1,2- and 1,3-glyceryl dinitrate (1,2- and 1,3-GDN), were evaluated in vitro, using full-thickness hairless mouse skin. GTN and the 1,2- and 1,3-GDNs were applied (a) in aqueous solution as pH 7.4 phosphate-buffered saline (PBS) and (b) incorporated into lipophilic ointment formulations. The cutaneous transformation of GTN to its dinitrate metabolites was detected, but no interconversion between 1,2-GDN and 1,3-GDN was observed. Following application of the nitrates in PBS solution, all three compounds exhibited steady-state transport kinetics. The steady-state flux of GTN (8.9 +/- 1.5 nmol cm-2 hr-1) was significantly greater (P less than 0.05) than those of 1,2-GDN (0.81 +/- 0.54 nmol cm-2 hr-1) and 1,3-GDN (0.72 +/- 0.20 nmol cm-2 hr-1). The corresponding permeability coefficient (rho) for GTN (20 +/- 3 x 10(-3) cm hr-1) was significantly larger than the corresponding values for 1,2-GDN (1.4 +/- 0.9 x 10(-3) cm hr-1) and 1,3-GDN (1.2 +/- 0.4 x 10(-3) cm hr-1), which were statistically indistinguishable (P greater than 0.05). Further analysis of the transport data showed that the differences between GTN and the GDNs could be explained by the relative stratum corneum/water partition coefficient (Ks) values of the compounds. The apparent partition parameters, defined as kappa = Ks.h [where h is the diffusion path length through stratum corneum (SC)] were 19.8 +/- 2.5 x 10(-2) cm for GTN and 1.91 +/- 1.07 x 10(-2) and 1.81 +/- 0.91 x 10(-2) cm for 1,2- and 1,3-GDN, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Organic nitrate metabolism and action: toward a unifying hypothesis and the future-a dedication to Professor Leslie Z. Benet.

Page N, Fung H J Pharm Sci. 2013; 102(9):3070-81.

PMID: 23670666 PMC: 3743928. DOI: 10.1002/jps.23550.


Pharmacokinetic characterisation of transdermal delivery systems.

Berner B, John V Clin Pharmacokinet. 1994; 26(2):121-34.

PMID: 8162656 DOI: 10.2165/00003088-199426020-00005.


Simultaneous pharmacodynamic modeling of the non-steady-state effects of three oral doses of 1,3-glyceryl dinitrate upon blood pressure in healthy volunteers.

Gumbleton M, Benet L J Pharmacokinet Biopharm. 1993; 21(5):515-32.

PMID: 8145129 DOI: 10.1007/BF01059112.

References
1.
Ogiso T, Iwaki M, Kanokogi A, Terao Y . Percutaneous absorption of 1,3-dinitroglycerin and a trial of pharmacokinetic analysis. Chem Pharm Bull (Tokyo). 1990; 38(10):2829-33. DOI: 10.1248/cpb.38.2829. View

2.
Guy R, Hadgraft J, Bucks D . Transdermal drug delivery and cutaneous metabolism. Xenobiotica. 1987; 17(3):325-43. DOI: 10.3109/00498258709043943. View

3.
Higo N, Hinz R, Lau D, Benet L, Guy R . Cutaneous metabolism of nitroglycerin in vitro. II. Effects of skin condition and penetration enhancement. Pharm Res. 1992; 9(3):303-6. DOI: 10.1023/a:1015822431178. View

4.
Higo N, Hinz R, Lau D, Benet L, Guy R . Cutaneous metabolism of nitroglycerin in vitro. I. Homogenized versus intact skin. Pharm Res. 1992; 9(2):187-90. DOI: 10.1023/a:1018925004345. View

5.
Gumbleton M, Benet L . Pharmacological activity of the dinitrate metabolites of nitroglycerin following their oral administration to healthy volunteers. Br J Clin Pharmacol. 1991; 31(2):211-3. PMC: 1368399. DOI: 10.1111/j.1365-2125.1991.tb05521.x. View